Your browser doesn't support javascript.
loading
Current and emerging target identification methods for novel antimalarials.
Challis, Matthew P; Devine, Shane M; Creek, Darren J.
Afiliação
  • Challis MP; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia.
  • Devine SM; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia.
  • Creek DJ; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria, 3052, Australia. Electronic address: Darren.creek@monash.edu.
Int J Parasitol Drugs Drug Resist ; 20: 135-144, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36410177
ABSTRACT
New antimalarial compounds with novel mechanisms of action are urgently needed to combat the recent rise in antimalarial drug resistance. Phenotypic high-throughput screens have proven to be a successful method for identifying new compounds, however, do not provide mechanistic information about the molecular target(s) responsible for antimalarial action. Current and emerging target identification methods such as in vitro resistance generation, metabolomics screening, chemoproteomic approaches and biophysical assays measuring protein stability across the whole proteome have successfully identified novel drug targets. This review provides an overview of these techniques, comparing their strengths and weaknesses and how they can be utilised for antimalarial target identification.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antimaláricos Tipo de estudo: Diagnostic_studies Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antimaláricos Tipo de estudo: Diagnostic_studies Idioma: En Revista: Int J Parasitol Drugs Drug Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália